1. Documented baseline target for treatment | 152 | 101 (66%) | −0.12, 0.08 |
2. Documented target of clinical remission (clinical remission = DAS28 <2.6) | 152 | 95 (63%) | −0.12, 0.07 |
3. Target of low disease activity (DAS28 >2.6 & <3.2) (LDAS) | 57 | 6 (11%) | −0.02, 0.38 |
4. Informed of treatment target | 152 | 135 (89%) | −0.15, 0.03* |
5. Informed of treatment strategy | 152 | 151 (99%) | 0.04, 0.32 |
6. DAS28 at each visit | 152 | 108 (71%) | −0.16, 0.02* |
7. If working, functional impairment recorded at each visit | 43 | 30 (70%) | −0.07, 0.34 |
8. Measure of disease activity at least every 3 months | 152 | 103 (68%) | −0.07, 0.19 |
9. Change to therapy if target not met | 136 | 83 (61%) | −0.03, 0.39 |